Sign up
Pharma Capital

WideCells hails roll out of 'first of its kind' CellPlan in Brazil

WideCells Group plc (LON:WDC) CEO Joao Andrade and CFO David Bridgland tell Proactive they've signed a definitive agreement with Brazilian cord blood storage facility, Hemocord Clinica Medica Ltd, to supply its stem cell services.

CellPlan Limited, a wholly-owned subsidiary of Widecells, will offer new and existing clients of Hemocord its stem cell healthcare insurance plan and medical concierge service.


View full WDC profile View Profile

WideCells expands its reach to Spain

View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.